The effectiveness of serum S100B, TRAIL, and adropin levels in predicting clinical outcome, final infarct core, and stroke subtypes of acute ischemic stroke patients

CONCLUSION: TRAIL and adropin serum levels were associated with poor clinical outcomes and greater infarcted area in acute ischemic stroke patients.PMID:35866730 | DOI:10.7705/biomedica.5943

Source: Biomedica : Revista del Instituto Nacional de Salud - July 22, 2022 Category: International Medicine & Public Health Authors: Ozge Altintas Kadirhan Okkes Taha Kucukdagli Bedia Gulen Source Type: research